The 230,000-square foot Ann Arbor facility closed by Pfizer in 2008, following a $250-million expansion six years earlier, is being scrutinized by owner University of Michigan. The school considers the pill-making and -packaging operation--part of a 2-million-square-foot complex--a potential magnet for public-private partnership. Article [1]
Links:
[1] http://www.annarbor.com/business-review/university-of-michigan-developing-strategy-for-ex-pfizer-sites-drug-manufacturing-complex/